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INTRODUCTION
                       Neonatal septicemia is a major cause of morbidity and mortality 
in the newborn1. Neonatal  septicemia is classified into early onset septicemia 
(EOS) and late onset septicemia (LOS) based on the age at onset2, 3. 
                         World Health Organization (WHO) estimates that there are  
about 5 million neonatal deaths occur globally per year. Ninety eight percent 
of them are occurring in developing countries.  Neonatal Death rate varies in 
developing countries between 11-68/1000 live birth2, 3. 
                         The most common causes of death in neonatal period is  
infection  (32%)  followed  by  birth  asphyxia  (29%)  and  prematurity  (24%). 
Neonatal infections currently cause 1.6 million deaths in developing countries 2. 
In India septicemia occur in 10.97-27/1000 live births and is the leading cause 
of neonatal mortality, accounting for one quarter to nearly half of all neonatal 
deaths4. In Tamil Nadu as per the study Kuruvil et al the incidence of neonatal  
septicemia is 9.8 per 1000 live birth Vellore 5. 
                       The microbial etiology of neonatal septicemia is variable and 
often  changes  temporally6. In  developed  countries  Group  B-  Streptococci 
(GBS) and Coagulase Negative Staphylococci (CONS) are the most common 
etiologic  agents  for  early  onset  and  late  onset  septicemia 
respectively. In developing countries Escherichia  coli,  Enterobacter  spp, 
Klebsiella  spp  and  Acinetobacter  precede  GBS and  CONS in  causing  EOS. 
Klebsiella spp, Pseudomonas spp, Salmonella spp, and Serratia precede CONS 
and Staphylococcus aureus in causation of LOS3. The source of infection in EOS 
is  generally  the  maternal  genital  tract.  Infants  with  EOS usually present  with 
respiratory  distress  and  pneumonia.The  source  of  infection  in  LOS  is  either 
nosocomial  or  community  acquired  and  the  neonates  usually  present  with 
pneumonia or meningitis 7.
                           Blood cultures are considered as the gold standard for  
diagnosis of neonatal septicemia. Nevertheless, their positivity varies widely 
(50  to  87%)  and  the  results  are  not  available  rapidly  for  therapeutic 
management. For this reason, other, faster, laboratory tests like white blood cell 
count  (WBC) and other biological  markers as interleukin-8, C-reactive protein 
(CRP), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α) and procalcitonin 
are used8.                                    
                               These biological markers, combined with clinical  
assessment,  increase  the  probability  of  correct  diagnosis  and  offer  the 
physicians’ greater  confidence in promptly initiating antimicrobial  therapy,  in 
parallel  with  supportive  care.  On  the  other  hand,  they  can  also  avoid  the 
indiscriminate  use  of  antibiotics  thereby  reducing  the  risk  of  developing 
multidrug resistant pathogens8. 
                               Resistance to commonly used drug is emerging as the 
most important problem globally. Antibiotic resistant bacteria are becoming an 
increasingly  difficult  problem  in  Neonatal  Intensive  Care  Units  (NICU)  2. A 
major risk are the unwell or premature babies, those needing additional support 
such as ventilation, intravenous fluids, or blood products, and those babies who 
stay in hospital for more than 48 hours3. Multidrug resistant Gram negative bacilli 
belonging to the family Enterobacteriaceae have been increasingly responsible 
for  infections  among  the  neonates  admitted  to  the  NICU  in  many  countries 
including  India  and  Klebsiella  pneumoniae constitutes  a  majority  of  these 
pathogens9.
                                 The most common mechanism of resistance in Gram  
negative  bacteria  is  by  the  production  of  β-lactamases  which  inactivate  β-
lactam  antibiotics.  Among  the  β-lactamases,  Extended  Spectrum  β-
lactamases (ESBLs) and AmpC β-lactamases are most commonly produced. 
AmpC  β-lactamases  are  more  important  because  they  confer  resistance  to 
narrow,  expanded,  broad-spectrum  Cephalosporins,  β-lactam  β-lactamase 
inhibitor  combinations and  Aztreonam, Earlier  the  AmpC β-lactamases  were 
presumed  to  be  chromosomally  encoded.  Recently  the  plasmid  mediated 
AmpC  β-lactamase  has  also  arisen  through  the  transfer  of  chromosomal 
genes  for  AmpC  β-lactamase  on  to  plasmids. This  transfer  has  resulted  in 
plasmid-mediated  AmpC  β-lactamases  in  isolates  of  E.coli, Klebsiella 
pneumoniae,  Salmonella  sp  and  Proteus  mirabilis thus  providing  a  new 
mechanism  of  resistance  for  those  originally  AmpC  deficient  bacterial 
strains10,11,12,72.
                                   Many clinical laboratories are not fully aware of the  
importance  of  plasmid  mediated  AmpC  β-lactamases.  Prevalence  of  this 
resistance mechanism appears to be increasing and has been responsible for 
nosocomial  outbreaks,  avoidable  therapeutic  failures  and  outbreaks  of 
multidrug resistant  Gram negative pathogens that  require  expensive control  
efforts13.
                                         Neonatal septicemia is a life threatening  
emergency. Diagnosis of neonatal septicemia is often difficult due to the 
minimal warning signs and symptoms both in preterm and term infants 2. 
Delay  in  diagnosis  and  treatment  with  appropriate  antibiotics  may  have 
devastating  consequences.  With  early  diagnosis  and  judicious  use  of 
antibiotics can bring down the neonatal morbidity and mortality substantially14. 
Surveillance is  needed to  identify the pathogens of  neonatal  septicemia as 
well  as  the  antibiotic  resistance  patterns  and  the  new  mechanism  of 
resistance15.  Hence  this  prospective  study  is  conducted  to  evaluate  the 
bacteriological  profile,  antibiotic  resistance  pattern  and  plasmid  mediated 
AmpC  β-lactamase  production  in  gram  negative  isolates  of  neonatal 
septicemia  from  the  neonates  admitted  in  NICU,  Tertiary  care  Hospital,  
Coimbatore. 
AIM:
         The aim of the present study is to identify the common Bacterial isolates of 
neonatal  septicemia  and  their  antibiotic  susceptibility  patterns  with  special 
reference  to  plasmid  mediated  AmpC β-lactamase  producing  Gram  negative 
isolates and also compare the CRP level with culture positivity.  
     
 OBJECTIVES:
1. To determine the bacteriological profile of neonatal septicemia.
2. To evaluate the antimicrobial susceptibility pattern of organisms isolated 
from neonatal septicemia.
3. To identify the prevalence of ESBL producers among the Gram negative 
isolates of neonatal septicemia.
4. To  identify  the  prevalence  of  plasmid  mediated  AmpC  β-lactamase 
producers among the Gram negative isolates of neonatal septicemia.
5. To compare the CRP level with culture positivity.
                                         REVIEW OF LITERATURE
                     Neonatal septicemia is a clinical syndrome characterized by  
systemic signs of infection and accompanied by bacteremia in the first month of 
life16,  17.Neonatal  septicemia    can  be  classified  into  two relatively  distinct  
illnesses  based  on  the postnatal  age  at  onset.  Early‐onset  neonatal 
septicemia (EOS) occurs in the first 7 days of life. Late‐onset septicemia occurs 
(LOS) within 7-28 days of life2, 3. 
Epidemiology  
                     
                       The reported incidence of neonatal sepsis varies from 3.5 to 8.9 
per 1000 live births in South America and the Caribbean, from 6.5 to 23 per 1000 
live  births  in  Africa,  and  from  7.1  to  38  per  1000  live  births  in  Asia.  By 
comparison, rates reported in the United States and Australasia range from 6–9 
per  1000  live  births  for  neonatal  sepsis3.  In  the  United  States,  septicemia 
accounts for 30% of the neonatal deaths. 
                         In India Septicemia is the commonest clinical category with an 
incidence of 23 per 1000 live births while the incidence of meningitis is reported 
to  be  3  per  1000  live  births.  Septicemia  continues  to  be  a  major  cause  of 
neonatal mortality in India accounting for one-fourth to nearly half of neonatal 
deaths. Fatality due to neonatal septicemia ranges between 40 and 65%16.
                        In developed countries, early onset neonatal septicemia   is often 
more severe and case fatality rate is higher than  late onset septicemia. As the 
latter is usually caused by CONS, the associated morbidity and mortality are low. 
In developing countries, this may not be the case; in some series, LOS has a  
higher case fatality rate, particularly when Gram negative bacteria are involved3
.
Risk factors 
                                 Neonatal, perinatal and various maternal risk factors may 
predispose the neonate to development of septicemia. Most of these risk factors 
may  be  prevented,  thereby  reducing  the  incidence  of  neonatal  septicemia17. 
Preterm  and  small  for  gestational  age  infants  are  more  prone  to  develop 
septicemia than term and appropriate for gestational age infants16.
Based on the studies from India, the following risk factors seem to be associated 
with an increased risk of EOS7, 17.
1. Low birth weight (<2500 grams) or prematurity63 
2. Febrile illness in the mother with evidence of bacterial infection within 2 
weeks prior to delivery
3. Foul smelling and/or meconium stained liquor.
4. Rupture of membranes >24 hours. 
5. Single unclean or > 3 sterile vaginal examinations during labor
6. Prolonged labor (sum of 1 and 2 stage of labor > 24 hrs)    
7. Perinatal asphyxia (Apgar score <4 at 1 minute)
Presence of  foul  smelling liquor or three of the above mentioned risk factors 
warrant initiation of antibiotic treatment. Infants with two risk factors should be 
investigated and then treated accordingly.
The  source  of  infection  in  LOS  is  either  nosocomial  (hospital-acquired)  or  
community-acquired and neonates usually present with septicemia, pneumonia 
or meningitis.
 Various  factors  that  predispose  to  an  increased  risk  of  nosocomial 
acquired LOS include 
1. Low birth weight63
2. Prematurity
3. Admission in intensive care unit
4. Mechanical ventilation 
5. Invasive procedures
6. Administration of parenteral fluids, Use of stock solutions.
 Factors that might increase the risk of community-acquired LOS include
1. Poor hygiene, 
2. Poor cord care
3. Bottle-feeding,  Prelacteal  feeds.  In  contrast,  breastfeeding  helps  in 
prevention of infections. 
Bacteriology            
                Microbiological spectrum of neonatal septicemia shows marked 
geographical  varations6.These  organisms  may  even   vary  at  different 
 times  within  the  same  place.
                Marico M Loureiro et al (2002) from Brazil reported that the most 
common  organism  was  Klebsiella  followed  by  Staphylococcus,  Serratia 
marcescens and Pseudomonas aeruginosa in causing neonatal septicemia18.
                   R N Musoke et al in the year 2000 from Kenya reported that the 
predominant  organisms  causing  neonatal  septicemia  were  Gram  negative 
bacteria (73.6 % of isolates) with Klebsiella species topping the list at 31 %19.      
                      Ziba mosayebi et al in the year 2003 from Iran reported that the 
most  common  pathogen  isolated  from  neonatal  septicemia  being  Klebsiella 
followed by Staph.aureus, E.coli, pseudomonas, Serratia and Acinetobacter.  In 
causing  EOS  Klebsiella  was  the  common  organism.  In  causing LOS 
Staphylococcus aureus was the common organism 20.                  
                       J L Yu et al in the year 2001 from China reported that the most 
common pathogen was  Staphylococcus followed by Escherichia coli in causing 
neonatal septicemia 21.                      
                              Rahman et al in the year 2002 from Pakistan reported that the 
most common organism isolated from neonatal septicemia being Escherichia coli 
followed by Staphylococcus, Pseudomonas and Klebsiella23.                    
                     Shaw CK et al in the year 2007 from Nepal reported that the most 
common  pathogen  isolated  from  Neonatal  septicemia  being  Staphylococcus 
aureus followed by Klebsiella, and E.coli22.
 Indian scenario 
                       In Indian studies, Gram negative organisms have been more  
frequently responsible for septicemia (65-85%) as compared to Gram positive 
organisms.  Commonly  found  organisms  are  Klebsiella,  E.coli,  pseudomonas, 
Staph. Aureus,  Coagulase negative  Staphylococcus, Enterobacter, Citrobacter, 
Proteus mirabilis, Serratia and Group B Streptococcus16.
                      According to .Mahabatra et al (2002) from Perhampur, Orrisa,  
Gram-negative  bacteria  (88.45%)  and  Gram  positive  bacteria  (11.6%)  were 
isolated from neonatal septicemia. Enterobacter.cloacae was maximally isolated 
bacteria followed by K.pneumoniae and E.coli1.
                     Diwakar et al in the year 2002 from Kerala reported that the most  
common pathogen isolated from Neonatal septicemia being CONS followed by 
Klebsiella, Pseudomonas aeruginosa, Enterobacter and Acinetobacter24.  
                           In a study by Vinodkumar et al (2007) from Karnataka, among  
the isolates of neonatal septicemia, Klebsiella (26.9%) was the most common 
infective organism followed by Staphylococcus aureus (20%), CONS (13.4%), 
E.coli (10.5%) and Acinetobacter species (6.1%) 17.  
                  According to Kurien Anil Kuruvilla et al from Tamil Nadu, E. coli and E. 
fecalis were the predominant organisms causing EOS, while Klebsiella and E. 
fecalis were the predominant organisms in LOS5.
Patho physiology
                        The fetus is protected from bacterial exposure by the membranes 
and  placenta.  It  has  also  been  shown  that  the  amniotic  fluid  has  inhibitory 
properties  against  bacterial  growth.  However,  fetal  bacteremia  may  occur  in 
preterm labor, and term neonates may have bacteremia or present symptoms at 
birth, suggesting that bacterial colonization may take place before birth. Some 
bacteria  (e.g.  Listeria  monocytogenes)  cause transplacental  infections via  the 
mother’s bloodstream. More commonly, however, bacterial exposure takes place 
in the amniotic cavity, or during the passage through the birth canal. Pyati et al  
reported that preterm neonates may be exposed to GBS in utero, whereas term 
neonates often may be exposed during the  passage through the birth  canal. 
Fetal colonization is likely to take place by aspiration of contaminated amniotic 
fluid, or by bacteria penetrating through injured skin or natural body openings. In  
most cases this colonization proceeds without causing disease. The mechanism 
by  which  bacterial  colonization  converts  to  invasive  disease  is  not  fully 
understood, but it is likely to reflect bacterial virulence, maternal immunological  
factors, and the competence of the neonatal immune system25, 26. 
                Once bacteria gain access to the bloodstream, mechanisms are 
activated by the  host  for  their  elimination.  Usually  the  bacteria  are  efficiently 
cleared by the monocyte-macrophage system after opsonization by antibody and 
complement. Sometimes, however, a systemic inflammatory response syndrome 
is established and can progress independently of the original infection. 
                Earlier it was believed that the bacteria or their cell wall components 
(endotoxins  of  Gram-negative  organisms  and  lipoteichoic  acid-peptidoglycan 
complex of Gram-positive bacteria) were largely responsible for the direct toxic 
effects  on  tissues.  Recent  research  indicates  that  the  physiologic  effects 
generated  by  bacterial  infections  are  largely  mediated  by  interaction  of  pro-
inflammatory  cytokines  activated  in  response  to  the  presence  of  microbial 
components within the vascular compartment16. 
Biological markers
                             As Marshall et al. pointed out, while many circulating or cell-
associated molecules such as white blood cell  count (WBC) ,interleukin 8, C-
reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α) 
and  procalcitonin  have  been  proposed  as  useful  markers  of  the  presence, 
severity, or response to therapy of septicemia. But none has been demonstrated 
to be 100% sensitive and specific, to have a clear utility in directing therapeutic 
decision-making27.
Procalcitonin
                       Procalcitonin (PCT) is a protein of 116 amino acids and a  
molecular weight of 13 kDa. It is a prohormone of calcitonin that is produced by 
the  parafollicular  cells  of  the  thyroid  gland,  and  is  intracellularly  cleaved  by 
proteolytic enzymes to form the active hormone50. This marker is also produced 
by  macrophage,  and  monocyte  cells  of  various  organs  in  severe  bacterial  
infection and sepsis. In 1993, a study identified elevated level of PCT in patients 
with bacterial infection52. Since then, PCT has become the most widely studied 
and reported putative biomarker for sepsis in children. While circulating levels of 
PCT in healthy subjects are below the limit of detection, production of PCT during 
inflammation  correlates  with  both  the  presence  of  bacterial  endotoxin  and 
inflammatory cytokines27. 
PCT levels  of  0.5-2  ng/ml,  2.1-10  ng/ml  and  >10  ng/ml  were  considered  as 
weakly positive, positive, and strongly positive, respectively64.
Interleukins 6 and 8
                 Interleukin-6  (IL-6)  levels  correlate  with  the  severity of  the  
inflammatory response, although they are not specific for bacterial infection. The 
concentration  of  IL-6  increases in  children with  sepsis,  and a  persistent  IL-6 
concentration >500 pg/mL may be useful  in  identifying pediatric  patients  with 
intra-abdominal  sepsis who are likely to have a prolonged length of stay and 
increased morbidity. In liver cells, it stimulates the synthesis of C-reactive protein, 
serum amyloid A, α1-acid glycoprotein, α1-antitrypsin, and fibrinogen, and is also 
responsible  for  myocardial  depression.  IL-8  is  a  chemokine  responsible  for 
migration of neutrophils and macrophages to the site of inflammation and is not 
normally present  in  high  quantities  in  healthy children.  It  has  been shown to 
serve as a diagnostic marker for bacterial sepsis in febrile, neutropenic children27.
C-reactive protein 
             C-reactive protein (CRP) is a real-time and low-cost biomarker. CRP is a 
major acute phase plasma protein, is synthesized by hepatocytes in response to 
infections or tissue injuries28. 
CRP was originally discovered by Tillett and Francis in 1930 as a substance in 
the  serum  of  patients  with  acute  inflamation  has  reacted  with  the  C 
polysaccharide of Pneumococcus  
         Pepys and Hirschfield (2003) and Marnell et al (2005) reported CRP as an 
indicator of acute infection and inflammation. Hengst( 2003), Black et al  (2004) 
and Sierra et  al(2004)  reported  that  Systemic infection  by Gram-positive  and 
Gram  negative  bacteria  raises  CRP  level   up  to  1000-fold   suggesting  its 
involvement in the immune response against most pathogens29.  It falls quickly 
after  efficient  elimination of  microbial  stimulus,  due to  its  short  half-life  of  19 
hours28.  
                       CRP directly binds to Streptococcus pneumonia (Volanakis and  
Kaplan, 1971), Neisseriae lactamica (Serino and Virji, 2000) and Haemophilus 
influenzae (Weiser et al, 1998) via repetitive phosphoryl choline moieties on the 
lipoteichoic acid or the lipopolysaccharide (LPS) of these pathogens has been 
shown.  Binding  of  CRP recruits  phagocytic  cells,  and  activates  the  classical 
complement pathway (Kaplan and Volanakis, 1974; Siegel et al, 1974), causing 
bacterial  clearance.  However  CRP  during  systemic  infection  in  vivo  is  not 
completely understood29.
                 Sensitivity and specificity of CRP varies in different studies in 
screening neonatal septicemia. 
               In a study by garland Suzanne et al  30, sensitivity was 67% and negative 
predictive  value  was  86%  in  screening  neonatal  septicemia.  In  a  study  by 
khassawneh et al31, sensitivity was 95% and negative predictive value was 98% 
in screening neonatal septicemia. In a study by Beger  et al,  CRP had 75% of 
sensitivity and 86% of specificity. In a study by Nutnar,et al, sensitivity was 100% 
and specificity was 94%, PPV and NPV were 91.6% and 100% respectively.  In 
Tehran study, sensitivity was 79% and negative predictive value was 97%, but 
poor positive predictive value of (36%), the specificity of it was 85%31.
Antibiotic resistance
                                      In neonatal intensive care units, infection by multidrug  
resistant Gram negative microorganisms is a threat for survival of premature and 
term newborns, since the therapeutic choices are limited for this group of patients 
and susceptibility of isolates in neonatal septicemia to the most commonly used 
antibiotics is decreasing around the world. Since emergence of resistance is a 
characteristic of the evolution of bacteria, it has been claimed as unavoidable33,51 ,
55,85.                    
.                             The various mechanisms of drug resistance in Gram-negative  
bacilli  include  enzyme  production  efflux  mechanisms  and  porin  deficiency11. 
Among  them  enzyme  β  lactamase  production  remains  the  most  important 
contributing factor to β lactam resistance.  The four major groups of β lactam 
antibioticss Penicillin, Cephalosporins, monobatams and carbapenems have a β 
lactam  ring  which  can  be  hydrolyzed  by  β-lactamases  resulting  in 
microbiologically ineffective compounds35.
                               Over the last two decades many new β lactam antibiotics  
have been developed that were specifically designed to be resistant to hydrolytic 
actions of β-lactamase. However, with this new class of drug that has been used 
to  treat  patients,  new types of  β-lactamases emerged by overproduction and 
mutation of lactamases10.  AmpC β-lactamase is one of these new types of β-
lactamases. In Gram negative bacteria these enzymes remain in the periplasmic 
space, where they attack the antibiotic before it can reach its receptor site35.
Classification of β lactamase enzymes.                                  
               The β lactamase enzymes are a diverse group of more than 340 
discrete  types  that  have  been  categorized  into  different  functional  groups, 
depending  on  their  antimicrobial  substrate  profile,  enzyme  inhibition  profile, 
enzyme net charge (PI), hydrolysis rate (Vmax), binding affinity (Km), isoelectric 
focusing,  protein  molecular  weight  and  aminoacid  composition36.  Ambler’s 
molecular classification is based on the nucleotide and amino acid sequences in 
these enzymes. To date, four classes are recognized (A to D), correlating with the 
functional classification. Classes A, C and D act by a serine-based mechanism 
whereas class B (metallo beta lactamases) needs divalent cation zinc for their  
action. However  the most recent and comprehensive classification is  the one 
given in 1995 by Bush, Jacoby and Medeiros. This classification system takes 
into account a number of properties simultaneously36,43.
Bush  Jacoby-Medeiros  Functional  Classification  of  Beta  lactamases  with 
correlation to Ambler molecular classification scheme36, 43, 74, 78.
Molecula
r Class 
Preferred Substrate Inhibite
d  by 
CA* 
Examples 
1 C Cephalosporins - AmpC, MIR-1 
2a A Penicillins + Gram  positive 
penicillinases
2b A Penicillins, Cephalosporins, + TEM-1  and  2, 
SHV-1 
2be A Penicillins,extended 
spectrum 
Cephalosporins,monobacta
ms 
+ TEM-3 to 26, SHV-
2 to 6 
2br A Penicillins +/- TEM-30 to 36 
2c A Penicillins, 
Carboxypenicillins 
+ PSE-1, 3 and 4 
2d D Penicillins, Cloxacillin +/- OXA-1 to 11 
2e A Cephalosporins + P. vulgaris 
2f A Penicillins, Cephalosporins, 
carbapenems 
+ NMC-A 
3 B Beta-lactams - CcrA 
4 ? Penicillins - B. cepacia 
                     Amongst the mechanisms of resistance to third generation  
cephalosporins,  production  of  ESBLs  and  AmpC  β-lactamases  are  the  most 
common.  AmpC  β-lactamases  are  clinically  important  because  they  confer 
resistance to narrow expanded, and broadspectrum cephalosporins, β lactam β 
lactamase inhibitor combinations and Aztreonam10, 11, 12.  
             
Plasmid mediated AmpC β-lactamases                         
                  AmpC β-lactamases are Group I cephalosporinases that confer  
resistance to a wide variety of β lactam antibiotics including alpha methoxy β 
lactams  such  as  Cefoxitin,  narrow  and  broad  spectrum  cephalosporins, 
Aztreonam, and are poorly inhibited by β-lactamase inhibitors such as clavulanic 
acid. 
                     Genes for AmpC β-lactamases are commonly found on the 
chromosomes  of  the  several  members  of  the  family  Enterobacteriaceae, 
including  Enterobacter,  Shigella,  Providencia,  Citrobacter  freundii,  Morganella 
morganii, Serratia and Escherichia coli. Plasmid mediated AmpC β-lactamases 
has arisen through the transfer of chromosomal genes for the inducible AmpC β-
lactamases on to plasmids. This transfer has resulted in plasmid mediated AmpC 
β-lactamases  in  isolates  of  Esch.  coli,  Klebsiella  pneumoniae,  Salmonella 
species, Citrobacter freundii, Enterobacter aerogenes and Proteus mirabilis12. 
 
 History 
                                  In 1976, Bobrowski et al 46 described a plasmid-mediated β 
lactamase indistinguishable from the AmpC enzyme of  E. coli in a strain of  P. 
mirabilis.   Unfortunately,  the original  plasmid was lost,  there was some doubt 
about the transfer experiments, and molecular studies were not done.  
In  1982,  Levesque  et  al47 reported  a  plasmid-mediated  cephalosporinase  in 
Achromobacter spp.  Regrettably, the original strain was lost, the β lactamase 
gene was not sequenced, and in retrospect the biochemical  properties of the 
enzyme resembled those of a group 2b broad-spectrum enzyme.
 
In 1983, Knothe et al48 reported the transfer of Cefoxitin resistance from Serratia. 
marcescens to Proteus or Salmonella spp., but resistance segregated on transfer 
to E. coli and no biochemical or molecular studies were done.
  
In  1989,  Bauernfeind  et  al  49 described a  K.  pneumoniae isolate  from South 
Korea that  could transfer  resistance to  Cefoxitin  and Cefotetan as well  as to 
Penicillins, oxyimino-cephalosporins, and Monobactams to E. coli.  The enzyme, 
termed CMY-1 for its cephamycinase activity, had an isoelectric point (pI) of 8.0 
and  was  more  sensitive  to  inhibition  by  Sulbactam  than  by  Clavulanate  or 
Tazobactam, suggesting that it might be a class C enzyme.
               However, the first proof that a class C β lactamase had been captured 
on a plasmid was provided by Papanicolaou et al., who described transmissible 
resistance to α methoxy- and oxyimino-β lactams mediated by an enzyme (MIR-
1) with the biochemical properties of a class 1 β lactamase and showed that part  
of  the  MIR-1  gene  was  90%  identical  to  the  amp  C gene  of  Enterobacter. 
cloacae.  Subsequently,  plasmid-mediated  class  C  β-  lactamases  have  been 
discovered worldwide37.
Nomenclature
                                 AmpC β-lactamases have been named with inconsistency  
typical  of  β lactamase nomenclature according to  the resistance produced to 
Cephamycins  (CMY),  Cefoxitin  (FOX),  and  Moxalactam (MOX)  or  Latamoxef 
(LAT), to the type of ßlactamase, such as Amp C type (ACT) or Ambler class C 
(ACC), and to the site of discovery, such as the Miriam Hospital in Providence,  
R.I. (MIR-1) or Dhahran hospital in Saudi Arabia (DHA). BIL-1 was even named 
after the patient (Bilal) who provided the original sample (D. J. Payne, personal  
communication) 37.
Epidemiological features                          
                       Plasmid mediated class C β-lactamases have been discovered  
most frequently in isolates of  K. pneumoniae and also in other naturally AmpC 
species such as K. oxytoca,  Salmonella, and P.  mirabilis. Some enzymes have 
been found in  E. coli, although this species can also increase production of its 
normally weakly expressed chromosomal AmpC enzyme by gene duplication or 
mutation in the  amp C promoter or attenuator with consequent enhanced gene 
expression.
 In Greece, plasmid-mediated LAT-2 (CMY-2) has been found in clinical isolates 
of Enterobacter aerogenes simultaneously with its appearance in clinical strains 
of K. pneumonia and E. coli.
In France plasmid-mediated ACC-1 has been found in both E. coli and Proteus. 
mirabilis isolates obtained from the same urine sample. 
In the United States, Ceftriaxone- resistant  Salmonella have begun to appear 
that owe their resistance to plasmid-mediated CMY-2 β lactamase. 
A  striking  feature  is  the  global  distribution  of  strains  producing  plasmid-
determined cephalosporinases. They have been found in Africa, Asia, Europe, 
Saudi Arabia, and America 
                             
           Most strains producing plasmid-determined AmpC enzymes have been 
isolated from patients after several days in the hospital. Affected patients have 
often had prolonged stays in intensive care units. Some patients had one or more 
surgical procedures, an underlying disease such as leukemia or cancer or were 
immune compromised after liver or kidney transplantation. Sources of organisms 
included cultures of urine (about 50% of isolates),  blood, wounds, sputum, or 
stool.  Some  isolates  were  recovered  in  mixed  cultures  with  other  potential 
pathogens. A majority of the patients had been treated with β lactam antibiotics 
including  Cefoxitin,  Moxalactam,  Cefmetazole,  Cefotetan,  or  Imipenem.  Many 
strains with plasmid-determined AmpC enzymes also produce TEM-1, TEM-2, or 
even an ESBL, such as SHV-537.
Susceptibility patterns.
                           Strains with plasmid-mediated AmpC enzymes were  
consistently  resistant  to  Aminopenicillins  (Ampicillin  or  Amoxicillin), 
Carboxypenicillins (Carbenicillin or Ticarcillin), and Ureidopenicillins (Piperacillin) 
and, among the Penicillins, these strains were susceptible only to Amdinocillin or 
Temocillin. The enzymes provided resistance to Cephalosporins in the oxyimino 
group (Ceftazidime, Cefotaxime, Ceftriaxone, Ceftizoxime, Cefuroxime) and the 
7α methoxy group (Cefoxitin,Cefotetan, Cefmetazole, Coxalactam). MICs were 
usually higher  for  Ceftazidime than for  Cefotaxime and for  Cefoxitin  than for 
Cefotetan. The enzymes were also active against the Monobactam Aztreonam. 
Susceptibility to Cefepime or Cefpirome was little affected and was unchanged 
for Carbapenems (Imipenem, Meropenem) 81,82, 84. 
                           
                                Alterations in antibiotic access to the enzyme can markedly  
change the susceptibility profile. With loss of outer membrane porin channels,  
Klebsiella.  pneumoniae strains  carrying  plasmids determining AmpC enzymes 
can  have  Imipenem  resistance.  Although  commercially  available  inhibitors 
especially Sulbactam, caused a modest reduction in MICs of Cefoxitin. Plasmid-
mediated AmpC enzymes were not susceptible to inhibitor combinations, with the 
possible  exception  of  Piperacillin-  Tazobactam.  Resistance  was,  however, 
blocked by BRL 42715 and Ro 47-8284
Enzymatic properties.
                      Plasmid-mediated AmpC type β lactamases have isoelectric points 
between  6.4  and  9.4.The  apparent  molecular  size  of  the  mature  plasmid-
mediated AmpC β-lactamases vary from 38 to 42 kDa with 378 to 386 amino acid 
residues. Kinetic properties were characteristic of chromosomal AmpC enzymes 
with  relative  Vmax  values  generally  10-fold  or  greater  for  Cephalothin  and 
Cephaloridine  than  for  Ampicillin  and Penicillin,  greater  activity  with  Penicillin 
than  with  Ampicillin,  and  low  hydrolysis  rates  for  oxyimino-  or  α  methoxy 
compounds. On the other hand, Km values for Cefoxitin, Cefotetan, Cefotaxime, 
Moxalactam,  or  Aztreonam  were  generally  less  than  those  for  Penicillin  or 
Ampicillin and much lower than the Km values for Cephaloridine, Cephalothin, or 
Cefepime as is typical of group 1 Cephalosporinases. The amino acid sequence 
of the enzymes revealed an active site serine in the motif Ser-X-X-Lys (where X 
is any amino acid) at residues 64 to 67 of the mature protein. A Lys-Ser/ Thr-Gly 
motif  has  been found at  residues 315 to  317 and plays  an essential  role  in 
forming the tertiary structure of the active site.
                      The plasmid-mediated enzymes can be divided into five or six 
clusters:  the  C.  freundii group  with  LAT  types  and  certain  CMY types,  the 
Enterobacter group with MIR-1 and ACT-1, the  M. morganii group with DHA-1 
and DHA-2, the H alvei group represented by ACC-1, and the Aeromonas group 
with MOX-, FOX-, and other CMY-type enzymes37, 42.
 
Genetic features
                                  Genes for the AmpC enzymes have been located on  
plasmids of sizes varying from 7 to 180 kb. A few of the plasmids have not been 
self-transmissible  but  are  transferable  by  transformation  or  mobilization. 
Plasmids  encoding  AmpC  enzymes  often  carry  multiple  other  resistances, 
including  resistance  to  Aminoglycosides,  Chloramphenicol,  Sulfonamide, 
Tetracycline,  Trimethoprim,  or  mercuric  ion.  A plasmid  encoding  a  FOX-type 
enzyme even carried  a  gene  for  Fluoroquinolone resistance.  Clinical  isolates 
often produce other β lactamases in addition to an AmpC enzyme. The bla genes 
may be on different plasmids, but often they coexist on the same plasmid37, 42. 
Detection
                                     There is no clear consensus regarding guidelines for  
performing  tests  for  the  phenotypic  screening  or  confirmatory  tests  for  the 
isolates that contain AmpC β-lactamases66. Sensitivity to Cephamycin such as 
Cefoxitin 30 μg disk (Hi-Media,) is tested by disk diffusion method and interpreted 
as per the Clinical Laboratory Standard institute (CLSI).Isolates with resistance 
or with decreased susceptibility (intermediate by CLSI criteria) to Cefoxitin are 
selected  for  further  study.  Furthermore,  not  all  strains  with  plasmid-mediated 
AmpC  enzymes  meet  the  CLSI  criteria  for  resistance  to  cephamycins  and 
oxyimino-cephalosporins. Isolates resistance to Cefoxitin can be studied further 
for cephamycin hydrolysis with the three-dimensional test, AmpC disk test and for 
β lactamase inhibitor effects. Unfortunately, inhibitors (BRL 42715, Ro 47-8284, 
Ro 48-1220, Ro 48-1256) that are active against AmpC enzymes are not readily 
available,  but  Cloxacillin  or  Cefoxitin  have been used to  block AmpC activity 
selectively  after  isoelectric  focusing.  Lack  of  inhibition  of  activity  against 
oxyimino- β lactams or cephamycins by Clavulanate is indirect evidence for the 
presence  of  an  AmpC  enzyme,  but  some  AmpC  enzymes  are  unusually 
susceptible to inhibition by Tazobactam
             A reference laboratory is needed for β-lactamase isoelectric focusing or  
gene localization37, 40.
 
Isoelectric focusing. 
                                   
               Crude AmpC β-lactamase extracts are subjected to analytical IEF on an 
ampholine  polyacrylamide gel  (pH 3.5  to  9.5;  Pharmacia,  Uppsala,  Sweden). 
Preparations from standard strains known to harbor TEM-12 (pI 5.25), TEM-10 
(pI 5.6), TEM-29 (pI 6.1), SHV-1 (pI 7.6), and ACT-1 (pI 9) plasmid-mediated β-
lactamases are used as controls. Then    β-lactamases are visualized with a 
0.2mg/ml nitrocefin solution (Oxoid Ltd., Basingstoke, England). A 1 mM solution 
of  potassium clavulanate  and  a  0.3  mM solution  of  Cloxacilin  were  used  to 
visualize general inhibitor characteristics9, 38, 67,68 and 69.
PCR and sequencing. 
                        
                  Multiplex PCR is performed to amplify six PABL group genes. A series 
of specific primers are used for the detection of DHA-1, CMY-2, MOX, ACC, EBC, 
FOX, TEM, SHV, and CTX-M. The PCR products are purified with a QIAquick 
PCR purification kit  (Qiagen, Hilden, Germany) and cloned into DH5. Plasmid 
DNA is prepared by using Qiagen columns and is sequenced on an ABI PRISM 
377 automated sequencer (Applied Biosystems, Foster City, CA)38,67,68,69. 
DNA fingerprinting. 
                   
                       Random amplified polymorphic DNA (RAPD) analysis is applied to  
type the PABL-producing isolates with the primer ERIC. Amplified PCR products 
are separated using 1.5% agarose gels and visualized by UV transillumination.  
DNA fingerprints are compared by visual inspection RAPD patterns are regarded 
as different if there are different bands on visual inspection.
Conjugation,plasmid analysis                   
                 Escherichia coli K12 J53 Azi r is used as the recipient strain. Cultures 
of donor and recipient cells are grown to saturation, and 0.1 ml of each is added 
to the brain heart infusion broth (5 ml) and allowed to stand at 37°C for 2 h. The 
mixture is then incubated with shaking for 3 h, and 0.1-ml samples were streaked 
onto Trypticase Soy Agar incorporated with 250 μg/ml of sodium azide and 10 
μg/ml of Cefotaxime. To confirm the presence of plasmids and to estimate their 
sizes,  plasmids  from  clinical  isolates  and  transconjugants  are  extracted, 
electrophoresed  on  a  0.7%  agarose  gel,  and  subjected  to  Southern 
hybridization38, 79,91.
Southern hybridization.                         
              
              Southern blot hybridizations are performed by standard methods with a 
blaCMY-2-specific  and  blaDHA-1-specific  digoxigenin  (DIG)-labeled  probe. 
Briefly,  purified plasmid DNA is transferred onto a positively charged Millipore 
nylon membrane by capillary action. DIG-labeled blaCMY-2-specific and blaDHA-
1-specific  detection  probes  are  generated  according  to  the  directions  of  the 
manufacturer. After prehybridization, hybridization   of the  membrane with  the 
denatured,   DIG-labeled probe 
(25 ng/ml of  hybridization solution) is done overnight at  65°C. The hybridized 
probes are immunodetected with anti-DIG-alkaline phosphatase38.
Detecting a plasmid-mediated AmpC enzyme in a strain with a native inducible ß 
lactamase or a coexisting ESBL is even more challenging. Given the difficulty in 
detecting  plasmid-mediated  AmpC β-lactamases,  their  prevalence  is  currently 
likely to be underestimated37.
                           Yi Li  et al38 (2003) from China reported that plasmid mediated 
AmpC β-lactamase were detected in 4.29% (29 isolates of DHA-1 and 1 isolate of 
CMY-2) of K. pneumoniae, 1.91% (11 isolates of DHA-1 and 12 isolates of CMY-
2) of E. coli, and 3.03% (1 isolate of DHA-1) of Klebsiella. oxytoca isolates.
                         Coudron et al83 Studied 1,286 consecutive, non repeat isolates 
from Omaha Medical Center collected between 1995 and 1997 and estimated 
that 1.6% of  E. coli isolates, 1.1% of  K. pneumoniae isolates, and 0.4% of  P. 
mirabilis isolates were Cefoxitin-resistant AmpC β-lactamase producers, mostly 
via transmissible plasmids.
                           The occurrence of AmpC β-lactamases in Delhi was reported by 
Manchanda & Singh, who found 20.7 per cent of the clinical isolates harboring 
Amp C β-lactamases39.
                            A. Subha et al44 (2003) from Chennai reported that,   twenty 
eight isolates (24.1%) of Klebsiella spp. and 12 (37.5%) of Esch. Coli were AmpC 
β-lactamase producers.
                            A.K. Ratna et al45 (2003) from Karnataka reported sixteen 
(3.3%) isolates were positive for AmpC β-lactamases.  Based on the species 9 
(3.3%)  Escherichia  coli,  4  (2.2%)   Klebsiella  pneumoniae,  2(5%)  Citrobacter 
freundii  and 1  (5.5%)  isolate  of  Enterobacter  aerogenes harbored  Amp  C 
enzymes. 
                            In a study by V. Hemalatha et al 40 (2007) from Chennai, AmpC 
β-lactamase was detected in 47.3 per cent isolates, four-fifths of which occurred 
in combination with ESBLs. Pure AmpC β-lactamases were detected only in 9.2 
per cent of the isolates40.
          
MATERIALS AND METHODS
                This prospective study was conducted on 273 Neonates with signs and  
symptoms of septicemia admitted in Neonatal Intensive Care Unit at Coimbatore 
medical  college  &  Hospital,  Coimbatore  over  the  period  of  14  months  from 
May’2008 to June’2009.
Approval was obtained from the ethical committee prior to conduct of this study. 
Informed consent was obtained from the parents of neonates.
Patient selection 
Inclusion criteria
                           Age<28 days
>30 weeks of gestation & Full term babies  
                          Presence of three or more clinical symptoms and signs of  
septicemia  like  lethargy,  poor  feeding,  irritability,  fever,  vomiting, 
abdominal  distension,  jaundice,  respiratory  distress,  hypothermia, 
cyanosis and convulsions.                                                                    
Exclusion criteria                        
                         Extreme prematurity <30 wks of gestation
                         Gross congenital anomalies 
                         Undergone surgery. 
The  name,  age,  sex,  address,  date  of  admission,  inpatient  number  and 
detailed clinical history of the patients were noted. A thorough head to foot 
general  examination,  systemic  examination  and  Respiratory  Distress 
Syndrome (RDS) scoring were carried out by the pediatricians.
Specimen collection 
             Samples collected
a.i. Blood
a.ii. CSF ( in case of suspected meningitis)
Blood sample collection 75, 76.
                                Venepuncture site was cleansed thoroughly with alcohol,  
followed by povidone- iodine, and again by alcohol. Povidone-iodine was applied 
in concentric circles moving outward from the centre. The skin was allowed to dry 
for  at  least  1  minute.  Two ml of  blood was withdrawn aseptically.  One ml  of  
collected blood sample was inoculated into a blood culture bottle containing 10 
ml Brain Heart Infusion broth for cultural isolation and remaining one ml of blood 
was preserved for serological test.
Cerebrospinal fluid specimen collection
               Term infants were placed in a seated position on the edge of the table, 
with trunk flexed forward, stabilised from the front by the assistant. The infant's 
shoulders and hips were held in order to maintain vertical alignment of the hips 
and shoulders during the procedure.  Lumbar Punctures were performed at or 
below the L4 level. CSF was allowed to drip into at least two tubes.  A minimum 
of 10 drops/tube was collected in separate sterile containers for microbiological 
and biochemical analysis. 
Safety precautions 
                 All samples were treated as potentially infectious and leak proof  
containers  were  used for  collection and  transportation  of  samples.  The 
containers  were  disinfected  by  treating  with  freshly  prepared  1  to  2% 
sodium hypo chlorite solution or sterilized by autoclaving. 
Specimen processing
Separation of serum from blood
                 The 1 ml blood preserved for serological  test was kept 
undisturbed  at  room  temperature  for  30  to  45  minutes  to  allow  clot 
formation and transferred to 4-80c for clot retraction for a minimum of 1to 2 
hours till serum was separated. 
                The clot was removed aseptically using sterile Pasteur pipette 
and the supernatant was centrifuged at low speed (1500 rpm for 5 to 10 
minutes) to remove the residual blood cells. Clear portion/serum was used 
for CRP Latex agglutination test. 
CSF 
                                     The CSF specimen for microbiological work was 
centrifuged at  1500-2000 rpm for  10-15 minutes.  After  centrifugation the 
deposit was used for Gram film and the remainder of the deposit used for 
cultural isolation.
Gram stain 75, 76. 
                 The gram staining was done as per the standard procedure 
mentioned  in  Appendix  I  and  the  stained  smear  was  examined 
microscopically under oil immersion field.
Cultural isolation 75, 76.
               The brain heart infusion broth with inoculated blood was incubated 
aerobically at 37°C. A subculture was done after 18 hours. The bottles were kept 
and observed for turbidity, gas production, haemolysis and any color change for 
seven  consecutive  days  in  case  of  absence  of  growth.  Media  used  for  sub 
culturing included Chocolate agar, Blood agar and Mac Conkey agar (HiMedia). 
                  The remaining sediment of CSF was inoculated on Blood 
agar,Choclate  agar  and  Mac  Conkey  agar.  The  inoculated  plates  were 
incubated at 370c for 18 to 24 hours.
                The isolates were identified by colony morphology, Gram staining, 
motility  and  the  following  biochemical  reactions  as  per  the  standard 
procedure77 mentioned in Appendix II.
1. Catalase test
2. Oxidase test
3. Coagulase test
4. Indole production test
5. Methyl red test 
6. Voges –proskauer test
7. Urease test 
8. Citrate utilization test
9. Triple sugar iron agar test
10.Carbohydrate utilization test
I. Antibiotic sensitivity testing 75, 76.
                                       Anti microbial susceptibility testing was performed by  
Kirby Bauer disk diffusion method. Commercially available Muller Hinton Agar 
culture medium and antibiotic disks (Himedia) were used.
Inoculum preparation
                         Using a sterile wire loop, 3-4 well isolated colonies of similar 
appearance from primary culture plate were inoculated into  2-3 ml  of  normal 
saline  and  subsequently  emulsified.  The  turbidity  was  adjusted  so  as  to 
correspond to the 0.5 Mc Farland standards.
Preparation of barium sulfate 0.5 Mc Farland standard.
                    A 0.5 ml of aliquot of 0.048mol/l(1.175%w/v Bacl2 2H2O)is added to 
99.5  ml  of  0.18  mol/l  H2SO4 (1%V/V)   with  constant  stirring  to  maintain  a 
suspension. 
Inoculation of test plates
                  After adjusting the turbidity of the inoculum suspension, a sterile  
cotton swab dipped in to the suspension. Excess fluid was removed by pressing 
and  rotating  the  swab  against  the  side  of  the  tube  above  the  level  of  the 
suspension. The surface of the Muller Hinton agar plate was streaked with the 
swab  evenly  over  in  three  directions.  Using  sterile  forceps  the  appropriate 
antimicrobial disks were placeded over the inoculated plate and not closer than 
about 25mm from disc to disc. Then the plates were incubated at 370c for 18 -24 
hrs.
Interpretation of zone sizes                                       
                         After overnight incubation, examined the plates to ensure the  
confluent or near confluent growth. Using a ruler held on the underside of the 
plate measured the diameter of each zone of inhibition in mm. The end point of  
inhibition  was  where  growth  starts.  The  sizes  of  zone  of  inhibition  were 
interpretated  by  referring  to  the  CLSI  standards,  and  the  organisms  were 
reported as susceptible, intermediate, or resistant to the agents that have been 
tested.
II.  Screening  for  ESBL  and  AmpC  β-lactamase  producing 
isolates. 
             Gram negative isolates resistant to third generation Cephalosporins 
(Cefotaxime, Ceftazidime,& Ceftriaxone) were screened for ESBL production and 
AmpC β-lactamase production by Novel Predictor Disk Placement Method.  
 Novel predictor disk placement method 87.
                                   C.Rodrigues et al (2004) followed this procedure to detect ESBL 
and AmpC β-lactamase production.          
                   The disk placement was designed in a novel fashion to assess  
ESBL  and  AmpC  β-lactamases.The  Ceftazidime  and  Ceftazidime 
+Clavulanic  acid  disks  were  kept  15-20  mm  apart  from  each  other. 
Imepenam ,an inducer was placed in the centre and on either side of it  at a 
15 mm distance,  were placed Ceftazidime and Cefotoxime (indicators of 
induction )in addition another inducer Cefoxitin was placed at 15mm from 
Cefotaxime .This was placed opposite to that of Ceftazidime +Clavulanic 
acid to avoid any effect of inducible β lactamases on the zone of inhibition 
of the latter.
1Imepenam, 2Cefotaxime, 
3Cefoxitin, 4Ceftazidime, 
5Ceftazidime+Calvulanic acid, 6Azteronam, 7Ceftritriaxone.
ESBL
• Zone  diameters  for  Cefotaxime<27  mm,Ceftazidime<22mm  and 
Ceftriaxone <25mm
• Susceptible to Cefoxitin
• Increase in zone size with addition of inhibitor by ≥ 5mm
  AmpC
• Resistanse to Cefoxitin
• No increase in zone size with addition of an inhibitor
•  (Inducible  Amp  C-Blunting  of  zone  towards  inducers  (imepenam. 
Cefoxitin)
III. Detection of ESBL production in gram negative isolates
                  ESBL production in gram negative isolates was further confirmed by 
Double disk potentiation test as per CLSI Standards.
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Phenotypic confirmatory test. (Double disk potentiation test )9, 10 
                         Ceftazidime (30 μg) disk  and a  Ceftazidime plus Clavulanic acid  
(Ca 30 μg + Caz 10 μg)  disk were placed at a distance of 20 mm apart on a lawn 
of culture of the suspected ESBL producing clinical isolates on MHA. The plates 
were incubated at 37°C overnight.
Interpretation
                     The test organism was considered to produce ESBL if the zone size  
around the Ceftazidime plus Clavulanic acid increased >5 mm in comparison to 
the third generation Ceftazidime disk alone. This increase occurred because the 
β lactamases produced by the isolates were inactivated by Clavulanic acid.
IV.  Detection  of  plasmid  mediated  AmpC  β-lactamases  in  Gram 
negative isolates
               Gram negative isolates positive for AmpC β-lactamase production 
in  screening  test  were  subjected  to  plasmid  mediated  AmpC  β-lactamase 
detection by the Modified Three Dimensional  Extract Method and AmpC Disk 
Test.
1. Modified Three Dimensional Extract Test 10,39,44,45,66.
                                          AMPC  enzyme production was tested by a 
modified three-dimensional test as described by Manchanda & Singh.
Preparation of AmpC enzyme extract.
                        10 to 15 mg fresh overnight growth from MHA was taken in a  
centrifuge tube. Peptone water was added and centrifuged 3000 rpm for 15 
min .Crude enzyme extract was prepared by repeated freeze thawing for 
five to seven times
Procedure
                         Lawn cultures of E.coli ATCC 25922 were prepared on MHA 
plates    and Cefoxitin (30 μg) disks were placed on the plate. Slits were cut 
using  a  sterile  surgical  blade  3  mm away from the  Cefoxitin  disk.10μg 
enzyme extract was added to a well made at the outer edge of the slit .The 
plates were incubated at 37°C overnight. 
Interpretation 
                       After incubation, plates were examined for either an indentation or  
a flattening of the zone of inhibition, indicating enzymatic inactivation of Cefoxitin 
(positive  result),  or  the  absence  of  a  distortion,  indicating  no  significant 
inactivation of Cefoxitin (negative result).
2. AMPC Disk test 11, 62,66.
                Plasmid mediated AmpC β-lactamases production was further tested 
by the AmpC disk test as described by Black et al62.
Amp C disk preparation
AmpC disks were prepared by applying 20ml of a 1:1 mixture of saline and 
100Xtris-EDTA to sterile  filter paper disks.  Several  colonies of  each test 
organism were applied to a disk.
procedure
     The surface of a Mueller-Hinton agar plate was inoculated with a lawn of 0.5 
McFarland matched suspension of Cefoxitin susceptible  E. coli ATCC 25922. A 
30 mcg Cefoxitin disk   was placed on the    inoculated surface of the Mueller-
Hinton agar. The AmpC disk was then placed almost touching the antibiotic disc 
with the inoculated disk face in contact with the agar surface. The plate was then 
inverted and incubated overnight at 35°C.
Interpretation  
After incubation, plates were examined for either an indentation or a flattening of 
the  zone  of  inhibition,  indicating  enzymatic  inactivation  of  Cefoxitin  (positive 
result),  or  the absence of  a  distortion,  indicating no significant  inactivation  of 
Cefoxitin (negative result).
V.  Confirmation  of  plasmid  mediation  in  AmpC  β-lactamases 
production .
Conjugation assay 44, 79, 81 ,91.
Transfer of cefoxitin resistance and AmpC β-lactamase production: 
Medium used for conjugation assay 
Trypticase soy agar
Trypticase peptone                    17g
Phytone peptone                         3g
Nacl                                             5g
K2HPO4                                     2.5g
Glucose                                      2.5g
Distilled water                               1L
P.H                                               7.4
Supplemented with Sodium Azide 250 μg/ml and Cefotaxime 10 μg/ml
Mating procedure
                          Transconjugation experiments were done following the 
procedure by Abigail et al with few modifications. Mating was performed 
with Escherichia  coli K12  J53  Azi r(kindly  provided  by  Professor  Dr  Raju  B 
Appala,  HOD,  Department  of  Microbiology,  PSG  Medical  College  &Hospital, 
Coimbatore.)  as the recipient  strain.  Overnight  brain heart  infusion (BHI) 
broth cultures (0.5 Mac Farland turbidity matched) of  the donor and the 
recipient strains were mixed in the ratio of 1:10. This mixed culture was 
incubated overnight at 37oC.
Selection of transconjugants.
                             Transconjugants were selected on  Trypticase Soy Agar 
plates containing 250 μg/ml of sodium azide and 10 μg/ml of Cefotaxime.  200 μl 
of the mixed culture after overnight incubation was spread on the selection 
plates with the help of the L-rod. The plates were incubated overnight at 
37oC.  The  plates  were  then  observed  for  the  presence  of  the 
transconjugants,  which  were  then  biochemically  identified.  The 
transconjugants were then tested for their antibiotic sensitivity pattern by 
the disc diffusion technique.
VI.  Minimum inhibitory concentration determination      MIC  of 
Ceftazidime and Cefepime was determined for  ESBL and AmpC β-lactamase 
producing  Gram negative  isolates  by  an  Epsilometer  test  (E  test).   A saline 
suspension of each isolate was adjusted to a McFarland standard of 0.5 and 
inoculated over the surface of the Muller Hinton agar plate by using sterile swab 
to produce an even inoculum. The Himedia Hicomb MIC strip was applied on the 
agar surface using sterile forcep. Then the plates were incubated for 18 hrs at  
35°C and the MIC was the point where the elliptical  zone of growth inhibition 
intersected  the  MIC  scale  on  the  E  test  strip.  The  concentration  range  of 
antimicrobial  on  the  E  test  strip  corresponds  to  two  fold  dilutions  in  a 
conventional MIC method.
VII. C reactive protein estimation 
                        
                       C reactive protein level was determined qualitatively and semi  
quantitatively by using CRP latex kit (Mediclone biotech pvt ltd) 
Principle
                         When a serum positive for C reactive protein is mixed with a latex  
reagent  (specially  selected  polystyrene  latex  particles  are  coated  with 
monospecific goat anti human CRP antibodies), a positive reaction is indicated 
by a distinctly visible agglutination of the latex particles in the test cell of the slide 
used. In specimen negative for C reactive protein the latex remains in a smooth 
suspension form, in the test cell.
Procedure
                One drop of test serum, positive control serum and negative control  
serum were placed on the separate cells of the slide. Then CRP latex reagent 
was added to all cells. Mixed and spread the fluid over the entire area of the 
particular cell with separate mixing sticks. The slide was tilted back and forth for 
2 minutes. CRP content of more than 6 mg/litre in undiluted serum specimen 
showed distinct agglutination. Sera with positive results in the screening were 
tested in the titration test (semi quantitative analysis). 
Semi quantitative analysis                                     
                                 0.9% saline solution was prepared. One drop of saline was  
placed on the separate cells of the slide. One drop of positive serum was added 
to the saline in the first cell. Mixed and took one drop from the first cell and added 
it into second cell. The same was done in subsequent cells. Finally one drop was 
discarded from the last  cell.  Then CRP latex reagent  was added to all  cells. 
Mixed and spread the fluid over the entire area of the particular cell with separate 
mixing sticks.  The slide was tilted back and forth for  2 minutes.  Last  dilution 
which showed distinct agglutination was noted.
Results were interpreted as per the following table present in the leaflet attached 
with a kit.
Dilution CRP (mg/litre)
(1:2) 12
(1:4) 24
(1:8) 48
(1:16) 96
(1:32) 192
             
    
RESULTS
                  During the study period, 273 neonates with signs and  
symptoms of septicemia admitted at Neonatal Intensive Care Unit, Coimbatore 
Medical College & Hospital were investigated with Blood culture & sensitivity and 
CRP  assay.  The  Resistant  Bacterial  isolates  were  analyzed  for  ESBL  and 
plasmid  mediated  AmpC  β-lactamase  enzyme  production  by  conventional 
Microbiological methods.
                             The Male:Female Neonates ratio of this study was 1.1:1.  
Out of 273 neonates, 173 (63 %) were less than 7 days old (EOS) and  100(37 
%) were in between 7-28 days after birth. (LOS) (Ref: Table 1).
                           The Blood culture isolation rate was only 33% (n=91). Out of  
this,  culture  positivity  was  more  in  EOS  cases  60  %(  n=55)  than  the 
LOS cases 40 %( n=36) (Ref: Table 2).
                            Gram negative bacterial isolates constituted 64 %( n=59) of the  
total bacterial isolates whereas Gram positive bacterial isolates constituted 36 %( 
n =32) (Ref: Table 4). 
                          Klebsiella pneumoniae (40%) was the most common organism  
among the GNB isolates  followed by Escherichia coli (10%), Enterobacter spp 
(7%), pseudomonas aeuriginosa (5%), and Acinetobacter spp (2%).In case of 
GPC  isolates,  Staphylococcus  aureus  constituted  (19%),  followed  by  CONS 
(13%) and streptococci sp (2%).
                 The most common organism isolated from both early and late onset  
septicemia was Klebsiella pneumoniae followed by Staph. aureus. (Ref: Table 5).
                The serum sample from all the suspected neonatal septicemic cases  
were tested for CRP using Latex agglutination test. It was found to be positive in 
131 cases, of which only 64 cases showed culture positivity. The sensitivity of 
CRP was 49% and specificity was 80%. Negative predictive value and positive 
predictive value were 63% and 70% respectively (Ref Table 3).
                 The antibiotic susceptibility testing for Gram positive organisms  
revealed  100% sensitivity  to  Vancomycin,  followed  by  82% to  Amikacin    & 
Cefepime. (Ref: Table 6). 
                  Gram negative organisms were 100% sensitive to Imepenam followed 
by 96% to Cefoperazone - sulbactum, 83% to Cefepime and 61% to Amikacin 
(Ref: Table 6).                
                 Out of 59 Gram negative isolates tested, 31 (53 %) were found to be 
resistant  to  third  generation  Cephalosporins  (Cefotaxime,  Ceftazidime,& 
Ceftriaxone).  Third generation Cephalosporins resistance was more common in 
Klebsiella pneumoniae (24) followed by E. coli (5), Pseudomonas aeruginosa (1) 
and Enterobacter sp (1) (Ref: Table 7).
                    Gram negative isolates (n=31) resistant to third Generation 
Cephalosporins were screened for ESBL and Amp C β lactamase production by 
Novel Predictor Disk Placement method. In screening test, 12 Klebsiella isolates, 
3 Escherichia  coli  isolates and 1 Pseudomonas aeuriginosa were positive for 
ESBL production and 12 Klebsiella isolates, 2 Escherichia coli  isolates and 1 
Enterobacter sp were positive for AmpC β-lactamase production. (Ref: Table 7).
                    ESBLs production among 16 GNB isolates were further confirmed 
by Disk Potentiation method using    Ceftazidime (30 μg) disk  and a  Ceftazidime 
plus Clavulanic acid (Ca 30 μg + Caz 10 μg)   as per CLSI guidelines and the 
results were found to be  similar to ESBL  screening test. 
                     The 15 GNB isolates showed Amp C β-lactamase production in  
screening  test  was  further  tested  for  confirmation  by  the  Modified  Three 
Dimensional Extract Method and AmpC Disk method.                
It  was  observed  9  (25  %)  Klebsiella  isolates  and  2  (22  %)  Escherichia  coli 
isolates were  positive  for  AmpC β-lactamase production,  but  Enterobacter  sp 
failed to produce Amp C β-lactamase in confirmatory test. 
                     The AmpC β- lactamase producing 9 Klebsiella isolates and 2  
Escherichia coli  isolates were subjected to Conjugation assay to demonstrate 
whether the  Amp C β- lactamase is plasmid mediated one by using Escherichia 
coli K12 J53 Azi r  (Recipient strain) as per the procedure described by  Abigail et 
al  with  few modifications.  The results  showed transfer  of  Cefoxitin  resistance 
(marker  of  Amp  C)  to  the  recipient  strain  from  all  the  9  AmpC β-lactamase 
producing Klebsiella pneumoniae strains. In case of Escherichia coli, only one 
strain showed the transfer of Cefoxitin resistance in the Conjugation assay. (Ref:  
Table 8).
              ESBL and AmpC β-lactamase producing Gram negative isolates were  
further  subjected  to  MIC  determination  by  Ceftazidime  and    Cefepime 
Epsilometer test strip. MIC of Ceftazidime was ≥32 μg /ml for both ESBL and 
AmpC  β-lactamase  producing  Gram  negative  isolates.MIC  of  Cefepime  was 
≥4μg /ml for ESBL producing Gram negative isolates and MIC of Cefefime was 
≤1μg for AmpC β-lactamase producing Gram negative isolates.  
Table -1:
Age and Sex wise distribution of septicemic neonates
   Characteristics      Male       Female     Total 
   < 7 days old
           EOS 
       95(55%)          78(45%)     173(63%)
  
   7-28 days old
         LOS
         63(63%)           37(37%)      100(37%)
         Total         158(58%)        115(42%)    273 (100%) 
Table -2:
Comparison of Blood culture positivity & time of onset of septicemia
Culture EOS LOS
Culture
Positive 91(33%)
55 (60%) 36 (40%)
Culture
Negative 
182(67%)
118(65%) 64(35%)
Total 173(63%) 100(37%)
                                                
Table -3:
       Correlation of culture positivity with C Reactive protein level
     
     Culture CRP positive CRP negative    Total 
Culture positive 
          
        64          27        91
Culture negative 
         
        67        115       182
         Total        131         142 273
Table-4:
Comparison of Gram positive  organisms with Gram negative 
organisms in neonatal septicemia.
Bacterial isolates No/Percentage
Gram positive 59 (64%)
Gram negative 32(36%)
               
   
Table-5: Pathogens isolated in neonatal septicemia.
Name of the organisms EOS
NO (%)
LOS
NO (%)
Total
NO (% )
Klebsiella pneumoniae 21 (38%) 15(42%) 36 (40%)
Staphylococcus aureus 11 (20%) 6 (16%) 17 (19%)
CONS 7 (13%) 6 (16%) 13 (15%)
Escherichia coli 7 (13%) 2(6%) 9 (10%)
Enterobacter spp 4 (7%) 3 (8%) 7 (7%)
Pseudomonas aeruginosa 3 (5%) 2(6%) 5 (5%)
Streptococci spp 2(4%) - 2 (2%)
Acinetobacter spp - 2(6%) 2 (2%)
Table -6:
Antibiotic sensitivity pattern of organisms isolated from neonatal 
septicemia.
Drugs Klebsiella E.coli Entero 
bacter
Pseudo
monas
Acineto 
bacter
Staphylo
coccus
Gentamycin 14% 33% 28%  20% 50%   -
Amikacin 44% 78% 43% 80% 100%  88%
Cephalexin 33% 44% 72% 80% 100%  76%
Cefotaxime 33% 44% 86% 80% 100% 76%
Ceftazidime 44 % 56% 86% 60% 100%     -
Ceftriaxone  31% 44% 72% 80% 100% 59%
Cefoxitin 67% 78% 86% 80% 100% 59%
Cefepime 67% 66% 100% 80% 100% 88%
Aztreonam 44% 44%  86% 80% 100%    -
Ciprofloxacin 64% 66% 86% 80% 100%  82%
Ofloxacin 72% 56% 86% 80% 100%  82%
Imepenam 1oo% 100% 100% 100% 100%      -
Piperaziline   33%  56%     - 80%   -    76%
Cs+sulbactum 91% 100%  -  -   -   -
Ampicillin      -    -    -    -   -   23%
Cloxacillin      -     -    -    -   -   23%
Amox-Cal 67% 78% 86% 80% 100%   59%
Erythromycin    -    -    -   -    -   59%
Azithromycin   -    -    -    -    -   88%
Oxacillin    -    -     -    -     -   59%
Vancomycin   -   -    -    -   -  100%
Table -7:
Screening for ESBL and AmpC β-lactamase production
Bacterial isolates
No of  3rd 
Gen Cep 
resistance 
isolates 
screened
No of ESBL 
positive 
isolates
No of Amp C 
β lactamase 
positive 
isolates 
K. pneumonia (36) 24(67%) 12(33%) 12(33%)
E. coli              9 5(55%) 3(33%) 2(22%)
Enterobacter    7 1(14%) 1(14%)
P. aeruginosa  5 1(14%) 1(20%)
Total               59 31(53%) 16(27%) 15(25%)
Table -8:
Detection of AmpC β-lactamase production
                                           
Bacterial 
isolates
Screening 
test positive 
Modified 
Three D
‘imensional 
test
Amp C disk 
test
Conjugation 
assay
Klebsiella 
pneumoniae 
(36)
    12(33%)      9 (25%)     9(25%)        9(25%)
Escherichia coli 
(9) 2 (22%) 2 (22%) 2(22%) 1 (11%)
Enterobacter 
(7) 1 (14%) - - -
DISCUSSION
            Septicemia is still  a major cause of mortality and morbidity in the 
neonates. Nowadays Gram negative microorganisms are increasingly reported 
as the major cause of neonatal septicemia particularly in Asian countries. The 
emergence  of  multidrug  resistant  Gram-negative  bacteria  is  mainly  due  to 
inadvertent use of broad-spectrum antibiotics.
               Two seventy three suspected septicemic neonates were investigated  
for septicemia. Among which 91 were culture positive. The positivity rate of Blood 
cultures was 33%.This culture positivity rate (33%) is comparable to that reported 
by  E Malakan Rad and N Momtazmanesh et al (2004)33 (30%), Mahabatra et al 
(2002)1  (40%) and by Bhattacharjee et al (2008)58 (48%).In contrast Shahanam 
ghelbi  et  al  (2008)34  reported 11% and Ziba Mosayebi  et  al  (2003)20 reported 
13% of  culture  positivity  rate:  this  discrepancy might  have arisen due to  the 
administration  of  antibiotics before blood collection either to  the  mother  or 
 to the baby   or  the  possibility  of  infection  with  viruses,  funguses  
or anaerobes .                 
                   In the present study, early onset septicemia was observed in 61% 
and late onset septicemia in 39% of the neonates. Early onset septicemia was 
more common than late onset septicemia which is compatible with the reports 
from  Choudry  habibur  rasul  et  al  (2007)2 (70.7%-EOS,  30%  -LOS), 
A.H.Movahedion et al (2006)32 (77.5 % -EOS, 22.5 %-LOS) and Vinod kumar et 
al (2008)17(55%-EOS, 47%-LOS).
        Contrasting results were published by kuruvilla et al (1997)5 who reported 
that late onset septicemia was more common than early onset septicemia. Shaw 
et  al  (2007)22 and Ziba Mosayebi  et  al  (2003)20 also reported that  late  onset 
septicemia was more common than early onset septicemia. Kuruvilla et al’s & 
Shaw’s et al study group comprised of babies delivered at their Institution and 
treated with prophylactic antibiotics. All  babies referred to our neonatal center 
with suspected septicemia were included in this study which explains the high 
incidence of early onset septicemia. 
                        In the present study sensitivity of CRP was 49%. Specificity was 
80%. Negative predictive value and positive predictive value were 63% and 70% 
respectively. Similar results were obtained in a study by Garland Suzane et al  
(2003)30.In contrast Khassawneh et al (2007)31,                      reported that CRP 
had a   sensitivity of (95%) and negative predictive value of (98%) in screening 
neonatal  septicemia31.Intriguingly  Nuntnar,et  al  reported  that  CRP  had  a 
sensitivity  of  100%  ,specificity  of  94%  ,PPV  and  NPV  of  91.6%  and  100% 
respectively. This difference could be due to the fact that these studies measured 
CRP quantitatively with different cut off points and different times from the onset 
of the signs of infection. However, it can be emphasized that a single CRP level 
measured  at  the  onset  of  infection  lacks  sufficient  sensitivity  to  be  useful  in 
identifying neonate with septicemia 56. In addition CRP cannot be recommended 
as a sole indicator of neonatal sepsis, but it may be used as part of a sepsis 
workup and in combination with other laboratory tests.      
                        The pathogens most often implicated in neonatal septicemia in 
developing countries differ from those seen in developed countries. In developed 
countries GBS and CONS are the more common etiological agents of neonatal 
septicemia. But  in  developing  countries  Gram  negative  organisms  are  more 
common  and  are  mainly  represented  by  Klebsiella  pneumoniae  followed  by 
Escherichia coli and pseudomonas aeuriginosa. It is not known whether these 
differences reflect the true differences in pathogens across the world, reflecting 
the  epidemiological  transition  in  some  countries  or  whether  it  reflects  an 
epidemiological bias.
                              In the present study, Gram negative organisms constituted  
64% of the total bacterial isolates causing neonatal septicemia whereas Gram 
positive organisms constituted 36%. This distribution pattern correlates well with 
the  results  published  by  Nalini  Agnihotri  et  al  (2004)90  from Chandigarh  who 
reported  that  Gram-negative  organisms  accounted  for  59%  of  all  positive 
cultures.  Another  study conducted by Mahapatra  et  al  (2002)1 in  Orissa  also 
reported  that  Gram-negative  bacilli  were  isolated  in  maximum  percentage 
(88.45%) of cases whereas gram-positive bacteria in 11.6% of culture. In contrast 
Shahsanam et al (2008)34 and Reza et al (2007)54  from Iran reported that Gram 
positive organisms constituted  the major group of isolates (62.1%),  68% 
respectively. 
             In the present study, among the Gram negative organisms Klebsiella 
pneumoniae (40%) was the most common organism followed by Escherichia coli  
(10%),  Enterobacter  spp  (7%),  pseudomonas  aeuriginosa  (5%),  and 
Acinetobacter  spp  (2%).Among  the  Gram positive  organisms  Staphylococcus 
aureus constituted (19%), followed by CONS (13%) and Streptococci sp (2%). 
This distribution pattern correlates well with the results published by Vinodkumar 
CS et al (2008)17 who reported that Klebsiella (26.9%) was the most common 
infective organism followed by Staphylococcus aureus (20%), CONS (13.4%), 
E.coli(10.5%) and Acinetobacter spp (6.1%). Same distribution pattern was also 
observed by kuruvilla et al (1997)5.  In contrast Shaw et al (2007)22 reported that 
Staphylococcus aureus was the most common organism isolated from neonatal 
septicemia.  Malakan  rod  et  al  (2004)33 also  reported  that  pseudomonas 
aeruginosa as the most common causative organism of neonatal septicemia.
                         Neonatal surveillance in developed countries generally identifies 
GBS and E coli as the dominant early onset septicemia pathogens and CONS 
the  dominant  late  onset  septicemia  pathogen  followed  by  GBS  and 
Staphylococcus  aureus.  In  developing  countries  E.coli,  GBS,  Enterobacter, 
Enterococcus and Listeria  are mostly associated with  early onset  septicemia. 
Klebsiella, Acinetobacter, Staphylococcus aureus and CONS are associated both 
with early onset septicemia & late onset septicemia. Pseudomonas aeruginosa, 
Salmonella and Serratia are more often associated with late onset septicemia. 
There appears to be a wide variety of bacteria causing early onset septicemia 
and late onset septicemia in developing countries. This variation may be true, but 
important confounders may include different definitions of early onset septicemia 
and  late  onset  septicemia,  different  inclusion  criteria  for  studies,  inability  to 
culture certain organism, small numbers and short period of surveillance. 
                     In the present study, Klebsiella pneumoniae was the most common 
organism in early and late onset septicemia. Mahapatra et al (2002)1  reported 
that  there  was  no  significant  difference  in  bacteriology  between  early  onset 
septicemia and late onset septicemia, which was also reported by Nalini Agnihorti  
et al (2004)90.
                   Majority of the Gram negative and Gram positive organisms isolated 
in  the  present  study  were  resistant  to  one  or  more  antibiotics.  This  is  in 
concurrence with other studies by Tallur et al (2000)4 and kuruvilla et al (1998)5. 
Present study revealed a very high degree of resistance of Gram negative bacilli  
not only to commonly used antibiotics, but also predominantly to broad spectrum 
Cephalosporins. These findings were compatible with other studies by Joshi et al 
(2000)60 and A.H Movahedian et al (2006)32. This is probably due to emergence 
of new variant of the existing strain as a result of mutations or may be plasmid 
borne. 
                  In the present study, Gram positive organisms were   100% sensitive  
to  Vancomycin  and  Gram  negative  organisms  were  100%  sensitive  to 
Imepenam. Similar findings were observed by Shaw C.K et al (2007)22. 
                    .  In the present study, resistance rate of Klebsiella pneumoniae,  
E.coli, pseudomonas and Enterobacter to third generation Cephalosporins were 
67%, 56%, 20% and 14%. respectively. Acinetobacter spp were 100% sensitive 
to third generation Cephalosporins..These findings were similar to the study by 
Ziba  mosayebi  et  al  (2003)20 reported  that  resistance  rate  of  Klebsiella 
pneumoniae,  E.coli,  Enterobacter  to  third  generation  Cephalosporins  were 
60%,30%  and,20%.Pseudomonas  and  Acinetobacter  were  100% sensitive  to 
third generation Cephalosporins.
                         Amongst the mechanisms of resistance to third generation  
Cephalosporins,  production  of  ESBLs  and  AmpC β-lactamases  are  the  most 
common.  AmpC  β-lactamases  are  clinically  important  because  they  confer 
resistance to narrow expanded and broad spectrum Cephalosporins, β lactam β 
lactamase inhibitor combinations and Aztreonam10, 11, 12. 
                            In the present study, Gram negative isolates resistant to third  
generation Cephalosporins were screened for  ESBL production and AmpC β-
lactamase production by Novel Predictor Disk Placement method.                 
                         ESBL production was further confirmed by Disk potentiation test  
method  as  per  CLSI  guidelines.  In  the  present  study,  ESBL production  was 
observed in 33% of Klebsiella isolates, 33% of Escherichia coli isolates and 20% 
of Pseudomonas isolates. These findings were lower than the results published 
by  Bhattacharjee  et  al  (2008)54  (ESBL production  by  Klebsiella.  pneumoniae 
62.7%, E. coli 46.5%), B.V.Krishna et al (2007)9 (ESBL production by Klebsiella 
pneumoniae 71.93 %) and Amita jain et al (2003)6 (ESBL production by Klebsiella 
sp 86.6%, E. coli 63.6%) but higher than the result published by Vinod Kumar et 
al (2004) (13.4 %) 89. 
                    Currently, CLSI documents do not indicate the screening and 
confirmatory tests that are optimal for detection of AmpC β-lactamases. However, 
several studies  have  been done on  various test  methods  namely,  the  Three 
Dimensional  test,  Modified  Double  Disk  test,  AmpC disk  test,  Inhibitor  based 
method71 employing inhibitors like boronic acids88,  Broth micro dilution method 
and  Cefoxitin  Agar  method82.  In  spite  of  many  phenotypic  tests,  isoelectric 
focusing  and  genotypic  characterization  by  various  molecular  methods  are 
considered  gold  standard  as  the  results  with  the  phenotypic  tests  can  be 
ambiguous and unreliable40. 
                   However these techniques are expensive and the requiring reagents 
are  costly  and  not  easily  available.  Hence  simple,  reliable  and  inexpensive 
phenotypic methods like Modified three dimensional test method and Amp C disk 
test method were used in this study.  Singhal et al (2005)66and Parul Sinha et al 
(2008) 86 also reported that Amp C disk test was easier, reliable and rapid method 
of detection of isolates that harboring AmpC β-lactamases65. 
                 AmpC β-lactamases production in screen positive isolates was further  
confirmed by the modified three dimensional  extract method and Amp C disc 
method.  Isolates  harboring  AmpC  β-lactamases  were  tested  for  plasmid 
mediation by conjugation assay. 
               In present study, 9 (25 %) Klebsiella isolates and 2 (22 %) Escherichia  
coli isolates were positive for AmpC β-lactamase production. In  K. pneumonia 
AmpC β-lactamase production is only plasmid mediated but in Esch. Coli hyper 
production of chromosomal mediated AmpC and plasmid mediated. Transfer of 
Cefoxitin  resistance  to  recipient  strain  was  observed  in  all  AmpC  producing 
Klebsiella isolates and 1 of 2 AmpC producing Escherichia coli isolate. 
                       Cefoxitin resistance in non AmpC producing  Klebsiella 
pneumoniae is often due to porin deficient mutants. The interruption of a porin 
gene by insertion sequences is a common type of mutation that causes the loss 
of  porin  expression  and  increased  Cefoxitin  resistance  in  Klebsiella. 
pneumonia73. In Esch. Coli hyper production of chromosomal AmpC with OMP F 
porin loss can produce similar resistance phenotype45.
                         In the present study, Plasmid mediated AmpC β-lactamase 
production was observed in 25% of Klebsiella isolates and 11% of Escherichia 
coli  isolates.  Similar  findings were  observed by A.  Subha et  al  (2003)44 from 
Chennai reported that, twenty eight isolates (24.1%) of  Klebsiella spp. and 12 
(37.5%) of  Esch. Coli were plasmid mediated AmpC β- lactamase producers. 
Manchanda & Singh et al from Delhi also reported 20.7 per cent of the clinical 
isolates  were  harboring  AmpC  β-lactamases39.   In  contrast  A.K.  Ratna  et  al 
(2003)45 from  Karnataka  reported sixteen  (3.3%)  isolates  were  positive  for 
plasmid  mediated  AmpC  β-lactamases.  Based  on  the  species  9  (3.3%) 
Escherichia  coli,  4  (2.2%)  K.pneumoniae,  2  (5%)  Citrobacter  freundii and  1 
(5.5%) isolate of Enterobacter aerogenes harbored Amp C enzymes.                  
                            In the present study MIC of Ceftazidime was≥32 μg /ml for  
ESBL  and  AmpC  β-lactamase  producing  Gram  negative  isolates.MIC  of 
Cefepime was ≥4μg /ml for ESBL producing Gram negative isolates and MIC of 
Cefefime was ≤1μg for AmpC β-lactamase producing Gram negative isolates. 
Similar results were obtained with the study by Hyunjoo Pai et al (2004) 81 and 
Jing-Jou Yan et al (2002)70.    
SUMMARY
 Two  seventy  three  suspected  septicemic  neonates  admitted  in 
NICU,  Coimbatore medical college, Coimbatore were studied over a 
period of 14 months from May 2008 to June 2009.
 One fifty eight male babies and one fifteen female babies were in 
the study.
 Blood Culture positivity rate was 33% 
 Early onset septicemia (61%) was more common than late onset 
septicemia (39% ).
 Comparing with culture positivity, sensitivity of CRP was 67% and 
specificity was 60% in diagnosis of neonatal septicemia.
 Gram  negative  organisms  constituted  64%  of  the  total  bacterial 
isolates.  Klebsiella  pneumoniae  (40%)  was  the  commonest 
organism  isolated.  This  was  followed  by  Staphylococcus  aureus 
(19%), CONS (13%), Escherichia coli (10%), Enterobacter spp (7%), 
Pseudomonas  aeuriginosa  (5%),  Aceinetobacter  (2%)  and 
streptococci (2%).
 Klebsiella pneumonia was the most common organism in early and 
late onset septicemia. 
 All Gram positive cocci were 100% sensitivity to Vancomycin
 All  Gram  negative  bacilli  were  100%  sensitivity  to  Imepenam 
followed by Cefoperazone - sulbactum 96%, Cefepime 83%   and 
Amikacin 61%.
 Gram  negative  isolates  (53%)  resistant  to  third  generation 
Cephalosporins were screened for ESBL production and AmpC β-
lactamase production by Novel Predictor Disk Placement Method.  
 The  confirmation  of  ESBL production  was  done  by  Double  Disc 
Potentiation Test.
 33% of Klebsiella isolates, 33% of Escherichia coli isolates and 20% 
of Pseudomonas isolates were ESBL producing strains. 
 The detection of plasmid mediated AmpC β-lactamase production 
was done by Modified Three Dimensional Test and Amp C Disk Test.
 Plasmid mediation in AmpC β-lactamase production was confirmed 
by Conjugation assay.
 25% of Klebsiella pneumoniae isolates and 11% of Escherichia coli 
isolates  were  plasmid  mediated  AmpC  β-lactamase  producing 
strains. 
                       
                                                              
   CONCLUSION 
                     The study of bacteriological profile of neonatal septicemia revealed 
early onset septicemia as more common than late onset septicemia. Klebsiella 
pneumoniae  was  the  most  common  bacterial    isolate  followed  by 
Staphylococcus  aureus,  CONS,  Escherichia  coli,  Enterobacter  spp, 
Pseudomonas aeuriginosa, Acinetobacter spp           and Streptococci spp in 
causing  neonatal septicemia. Single CRP        level measured at the onset of  
infection lacked sufficient sensitivity            to beuseful in identifying neonatal  
septicemia.  Antimicrobial        susceptibility  revealed Imepenam as the most 
effective antibiotic                          followed   by Cefoperazone + Sulbactum,  
Cefepime  and Amikacin   against   Gram negative isolates. Among the Gram 
negative isolates of   the neonatal septicemia 27% were ESBL producers and 
22%  were  plasmid  mediated    AmpC   β-lactamase  producers.  Failure  to 
distinguish         AmpC β-lactamase producers from ESBL producers will lead to  
inappropriate antimicrobial treatment and may result in increased mortality. The 
ability to detect and distinguish between AmpC and ESBL producing organisms 
has therapeutic importance as well as epidemiological significance.
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APPENDIX-I:
           
Gram staining
Prepare a smear by placing 1 to 2 drops of sediment on a clean grease 
free glass slide 
Air dry and heat fix the slide
Cover the slide with methyl  violet solution and allow to act for about 1 
minute
Wash with clean water 
Then cover the smear with freshly prepared Grams iodine solution and 
wait for 1 minute
Then wash the smear with clean water
Decolorize with 100% acetone for 2- 3 seconds
Wash the slide immediately
Apply counter stain dilute carbol fuschin for 30 seconds
Wash with water and blot dry
The stained  smear  was  examined  microscopically  under  oil  immersion 
field 
                         
APPENDIX- II:
Catalase test
Principle
The test is performed to determine the presence of catalase enzyme in an 
organism.
Method
Pure growth of the organism was transferred from the agar to a clean slide 
with a glass rod. A drop of 3% hydrogen peroxide was added to the growth.
Interpretation
Evolution of bubbles from the colony was considered as a positive test.
Oxidase test
Principle
The test is performed to determine the presence of enzyme oxidase in an 
organism.
Reagent
Tetra methyl para phenylene diamine dihydrochloride 1% aqueous solution.
Method
A small portion of colony was removed with wooden stick and rubbed over 
the filter paper soaked with oxidase reagent 
Interpretation 
 Positive oxidase test was indicated by developmentof a purple color. 
Slide Coagulase test
Principle 
The test is performed to determine the ability of an organism to clot plasma 
by the action of the enzyme coagulase, and is used to differentiate between 
Staphylococcus aureus and CONS. This test detects bound coagulase.
Method 
A single colony was emulsified in a drop of saline on a clean glass slide. 
Similar suspensions were made for positive and negative control stains to 
confirm the proper  reactivity  of  plasma.Traces of  plasma was added to 
milky suspensions of test and control strains.
Interpretation 
The test was read as positive if visible clumping occurs within 10 seconds 
and read as negative if clumping was absent. 
Indole test 
Principle
The test is performed to determine the ability of an organism to split indole 
from the tryptophan molecule Indole reacts with aldehydes to produce a 
red color
Medium -Peptone water
Method
Pure single  colony was inoculated into peptone water  and incubated at 
37oc  for  18-24  hrs  0.2  ml  of  Kovacs  reagent  paradimethyl 
aminobenzaldehyde was added to culture broth.
Interpretation
A positive  reaction  was  indicated  by  the  formation  of  pink  ring  at  the 
junction.
Citrate utilization test
Principle 
The test is performed to determine the ability of the microorganisms utilize 
citrate as sole carbon source and grow. The usage of citrate can be tested 
for alkali production by using a suitable PH indicator.
Medium 
Simmons  citrate  medium:  Magnesium  sulfate  0.2gram,Ammonium 
dihydrogen  phosphate  1  gram,Dipottasium  phosphate  1  gram,  Sodium 
citrate 2 gram, Sodium chloride 5 gram, Agar 20 gram, Bromothymol blue 
0.08 gram, Distilled water 1000 ml.
Method       
 A drop of  4-6 hrs growth of  bacterium in broth was inoculated on the 
Simmons citrate agar slant and incubated at 370c for 18-24 hrs.
Interpretation
The test was read as positive reaction when the indicator turned blue and 
negative reaction when no change in color occurred.
Methyl red test
Principle
To test the ability of the organism to produce and maintain stable acid end 
products from glucose fermentation.
Method
Test  organism  was  inoculated  into  glucose  phosphate  broth.  Then  the 
broth was incubated at 370c for 48 hrs. 
Then O.2 ml of methyl red reagent was added to the broth.
Interpretation
Reddening of the supernatant was considered as positive. 
Urease test 
 Principle 
The  test  is  performed  to  determine  the  ability  of  microorganisms  to 
produce the enzyme urease.The occurrence of this enzyme can be tested 
for  by growing the organism in the presence of  urea and subsequently 
testing for alkali (NH3) production by using a suitable pH indicator.
Medium
Christensen’s urease medium: Peptone 1.0 gram, Glucose(o.1%) 1.0 gram, 
Sodium chloride 5.0 grams, Mono potassium phosphate 2.0 grams, Phenol 
red 0.012 gram,agar 15-20 grams, distilled water1000 ml
Method 
A drop of  4-6 hours old bacterial  broth culture was inoculated over the 
entire slope surface. Then the medium was incubated at 37 0 c for 18 to 24 
hours.
Interpretation 
The test was read as positive reaction when the indicator turned purple –
pink, and negative reaction when no change in color occurred.
Voges –Proskauer test:
Principle 
The test is performed to determine the ability of the micro organisms to 
ferment glucose with the production of acetyl methyl carbinol (acetoin).
Medium- Glucose phosphate broth
Method
Test  organism  was  inoculated  into  glucose  phosphate  broth.  Then  the 
broth was incubated at 370c for 48 hrs. Subsequently 0.2ml of VP reagent A 
(5% alpha naphthol) and 0.2 ml of VP reagent B (40% KOH) were added and 
the contents were shaken vigorously for 30 seconds.
Interpretation
Reddening  of  the  supernatant  within  5-10  minutes  due  to  acetoin 
production was read as positive reaction. A negative reaction was indicated 
by the development of yellow color.
Carbohydrate utilization test
Principle 
The  test  is  used  to  determine  the  ability  of  an  organism  to  ferment  a 
specific  carbohydrate  which is  incorporated in  a  basal  medium,  and  to 
produce  acid  or  acid  with  visible  gas.  Sugars  tested  included  glucose, 
lactose, sucrose, maltose, mannitol, trehalose, xylose, arabinose, sorbitol 
and starch.
Medium
Sugar 1.0 gram, Nutrient broth base 100 ml, Bromothymol blue indicator 1.2 
ml 
Method 
Test organism was inoculated into each sugar medium and subsequently 
incubated at 370c for 24 hrs
Interpretation 
A positive test was shown by yellow coloration of the medium due to acid 
production: 
no color change, due to inability of the microorganisms to ferment sugars, 
was read as negative reaction.
Triple sugar iron agar test
Principle 
The test is performed to determine the ability of an organism to ferment a 
specific carbohydrate incorporated in a basal medium, with or without the 
production  of  gas  along  with  the  determination  of  possible  hydrogen 
sulfide production
Method 
Test organism was inoculated on TSI agar by stab the butt and streak the 
slant with straight wire and incubated subsequently for 24 hours.
Interpretation 
Glucose fermentation was shown by a yellow butt and red slant .Glucose, 
sucrose and lactose fermentation were shown by a yellow butt and slant. 
Gas production was indicated by Bubbles in the medium. Hydrogen sulfide 
production was identified by presence of black precipitate.       
                                                
APPENDIX-III:
Antibiotics
Disc content 
μg
Sensitive
mm ≥
Intermediate 
mm
Resistant
mm≤
Gentamycin 10 15 13-14 12
Amikacin 30 17 15-16 14
Amox-cal 20/10 18 14-17 13
Cephalexin 30 18 14
Cefotaxime 30 23 15-22 14
Ceftazidime 30 18 15-17 14
Ceftriaxone 30 21 14-20 13
Cefoxitin 30 18 15-17 14
Aztreonam 30 22 16-21 15
Cefepime 30 18 15-17 14
Ciprofloxacin 5 21 16-20 15
Ofloxacin 5 16 13-15 12
Imepenam 10 16 14-15 13
Gram negative Isolates were tested for following antimicrobial antibiotic discs and 
the zone size interpretative chart as comparable with CLSI standards
Gram positive isolates were tested for following antibiotic discs and the 
zone size interpretative chart as comparable with CLSI standards
antibiotics
Disc content 
mcg
Sensitive
mm ≥
Intermediate 
mm
 
Resistant 
mm ≤
ampicillin 10 29 28
Cloxacillin 5 18 17
Amox-cal 20/10 20 19
Cephalexin 30 18 14
Cefotaxime 30 23 15-22 14
Cefoxitin 30 18 15-17 14
Ceftriaxone 30 21 14-20 13
Cefepime 30 18 15-17 14
Erythromyc
in 
15 23 14-22 13
Azithromyci
n 
15 18 14-17 13
Amikacin 30 17 15-16 14
Ciprofloxaci
n 
5 21 16-20 15
Ofloxacin 5 18 15-17 14
Oxacillin 1 13 11-12 10
Vancomyci
n 
30 15-17
                                             PROFORMA
  
Name 
 Age <7 days
           >7days<28 days
Sex F/M
Parent/guardian
           Address 
Birth weight
Term 
Nature of Delivery 
           Present history
                               H/O Poor cry, Poor feeding, Irritability, Fever, Vomiting
                               H/O convulsions                   
                               H/O Antibiotic use         
           Examination of newborn
                    Cry                                                        HR
                    Activity                                                 RR
                    Color                                                    SPO2
                    Tone
                    Posture
                   Temperature 
            RDS SCORING
                       RR, Cyanosis, Retraction, Grunting & Airway
Systemic examination
                CVS          SIS2 heard                                                            
                                  No murmur 
                RS             Normal vesicular birth sound heard              
                                  No added sound 
              Abdomen     Soft, mild distension
                        Spleen not palpable 
               CNS             Tone                            
                                     Reflexes     
                                                                                 
                                                      
  Investigations 
                              Haemogram
                               CRP
                               Blood culture &Sensitivity
                                                                
                                                                 
